A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis

Journal of Infectious Diseases

Volumn 197, Issue 2, 2008, Pages 266-269

  Kindberg, Elin ^a,b   Mickiene, Aukse ^c,d,e   Ax, Cecilia ^a   Åkerlind, Britt ^b   Vene, Sirkka ^d   Lindquist, Lars ^c   Lundkvist, Åke ^d   Svensson, Lennart ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CHEMOKINE RECEPTOR CCR5 GENE; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; LITHUANIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TICK BORNE ENCEPHALITIS; ALLELE; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; HOSPITALIZATION; MENINGOENCEPHALITIS; PATHOPHYSIOLOGY;

ALLELES; ENCEPHALITIS, TICK-BORNE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; LITHUANIA; MENINGOENCEPHALITIS; RECEPTORS, CCR5; SEVERITY OF ILLNESS INDEX;

EID: 39149127314     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/524709     Document Type: Article

References (15)

1. Lindenbach BP, Rice, CM. Flaviviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Griffen DE, ed. Fields virology. Vol. 1 (4th ed.). Philadelphia: Lippincott Williams & Wilkins, 2001:991- 1003.
2. Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antiviral Res 2003; 57:129-46.
3. Haglund M, Gunther G. Tick-borne encephalitis - pathogenesis, clinical course and long-term follow-up. Vaccine 2003; 21(Suppl 1):S11-8.
4. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 2003; 21(Suppl 1):S36-40.
5. Puchhammer-Stockl E, Kunz C, Mandl CW, Heinz FX. Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay. Clin Diagn Virol 1995; 4:321-6.
6. Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H. Visualization of Central European tick-borne encephalitis infection in fatal human cases. J Neuropathol Exp Neurol 2005; 64:506-12.
7. Wong MM, Fish EN. Chemokines: attractive mediators of the immune response. Semin Immunol 2003; 15:5-14.
8. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 2005; 202:1087-98.
9. Glass WG, McDermott DH, Lim JK, et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 2006; 203:35-40.
10. Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L. Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis 2002; 35:650-8.
11. Kindberg E, Hejdeman B, Bratt G, et al. A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection. AIDS 2006; 20:685-9.
12. Libert F, Cochaux P, Beckman G, et al. The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in northeastern Europe. Hum Mol Genet 1998; 7:399-406.
13. Stephens JC, Reich DE, Goldstein DB, et al. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 1998; 62:1507-15.
14. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-77.
15. Lucotte G. Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis. Infect Genet Evol 2002; 1:201-5.